Entering text into the input field will update the search result below

Nasdaq gives Aytu BioPharma 180-day extension to comply with bid price rule

Nov. 23, 2022 1:56 AM ETAytu BioPharma, Inc. (AYTU) StockBy: Meghavi Singh, SA News Editor
  • The Nasdaq has granted Aytu BioPharma (NASDAQ:AYTU) a 180-day extension to regain compliance with the stock exchange's minimum bid price requirement.
  • AYTU now has until May 22, 2023, to regain compliance.
  • The compliance will be regained if at any time until May 22, 2023, the bid price per share closes at or above $1.00 for a minimum of 10 consecutive trading days.
  • If the company does not comply with the minimum bid price requirement during the 180-day grace period than its shares are subject to delisting.
  • AYTU shares were trading +4.31% after-hours.

Recommended For You

More Trending News

About AYTU Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AYTU--
Aytu BioPharma, Inc.